Incyte (INCY) Invested Capital (2010 - 2026)
Incyte (INCY) reported Invested Capital of $5.7 billion for Q1 2026, up 52.65% on a YoY basis from $3.7 billion in Q1 2025, and up 8.84% quarter-over-quarter from $5.2 billion in Q4 2025.
Incyte (INCY) Invested Capital (2010 - 2026) Analysis & Trends
Incyte has reported Invested Capital for 17 years, with the latest figure at $5.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital rose 52.65% year-over-year to $5.7 billion; the trailing twelve-month figure through Mar 2026 stood at $5.7 billion (up 52.65% YoY), and the FY2025 full-year result was $5.2 billion, up 49.25% from the prior year.
- Invested Capital for Q1 2026 stood at $5.7 billion, up from $5.2 billion in the prior quarter.
- The five-year high for Invested Capital was $5.7 billion in Q1 2026, with the low at $3.0 billion in Q2 2024.
- Historically, Invested Capital has averaged $4.4 billion across 5 years, with a median of $4.4 billion in 2022.
- Annual changes were most pronounced in 2024 — Invested Capital slumped 36.5% — and 2026, when it jumped 52.65%.
- Incyte's Invested Capital stood at $4.4 billion in 2022, then rose by 18.6% to $5.2 billion in 2023, then tumbled by 33.26% to $3.5 billion in 2024, then soared by 49.25% to $5.2 billion in 2025, then advanced by 8.84% to $5.7 billion in 2026.
- The last three Invested Capital figures came in at $5.7 billion (Q1 2026), $5.2 billion (Q4 2025), and $4.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 5.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.66 Bn |
| Dec 31, 2025 | 5.20 Bn |
| Sep 30, 2025 | 4.70 Bn |
| Jun 30, 2025 | 4.22 Bn |
| Mar 31, 2025 | 3.71 Bn |
| Dec 31, 2024 | 3.49 Bn |
| Sep 30, 2024 | 3.21 Bn |
| Jun 30, 2024 | 3.03 Bn |
| Mar 31, 2024 | 5.43 Bn |
| Dec 31, 2023 | 5.22 Bn |
| Sep 30, 2023 | 4.97 Bn |
| Jun 30, 2023 | 4.78 Bn |
| Mar 31, 2023 | 4.50 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.26 Bn |
| Jun 30, 2022 | 4.12 Bn |
| Mar 31, 2022 | 3.90 Bn |
| Dec 31, 2021 | 3.81 Bn |
| Sep 30, 2021 | 3.19 Bn |
| Jun 30, 2021 | 2.98 Bn |